{"id":1138,"date":"2026-05-18T18:15:47","date_gmt":"2026-05-18T16:15:47","guid":{"rendered":"https:\/\/nuklid.network\/home-2"},"modified":"2026-05-18T18:46:26","modified_gmt":"2026-05-18T16:46:26","slug":"home-2","status":"publish","type":"page","link":"https:\/\/nuklid.network\/en","title":{"rendered":"Home"},"content":{"rendered":"

Shape the future of radiopharmacy<\/h1>\n<\/div><\/div><\/div>
<\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>

Welcome to the platform for
radiopharmacy in Saxony<\/h2>\n<\/div><\/div><\/div>

nukliD\u00ae<\/sup>, the beating heart of radiopharmacy in Dresden, offers pioneering solutions that innovatively advance nuclear medicine and open up new perspectives for the treatment of cancer. We are a dynamic network of experts and pioneers who are actively shaping the future of radiopharmacy together. Our partner companies in the greater Dresden area are looking for committed and qualified employees to shape the future of the innovation cluster together. <\/p><\/div><\/div><\/div><\/div>

Mission<\/h2>\n<\/div><\/div><\/div>

Our mission is to push the boundaries of radiopharmacy and develop breakthrough therapies,
that improve the lives of patients worldwide.<\/p><\/div><\/div><\/div><\/div>

\n\n\n

Innovation<\/h2>\n<\/div><\/div><\/div>

We promote a culture of innovation in order to constantly find new ways to improve medical care.<\/p><\/div><\/div>

\n\n\n

Excellence<\/h2>\n<\/div><\/div><\/div>

We aim for the highest quality in everything we do.<\/p><\/div><\/div>

\n\n\n

Teamwork<\/h2>\n<\/div><\/div><\/div>

Together we achieve more - we value the cooperation and commitment of each individual.<\/p><\/div><\/div><\/div><\/div>

<\/div><\/div>

News<\/h2>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Featured<\/span><\/figure>

21. January 2026<\/h3>\n<\/div><\/div><\/div>

Radiopharmacy theme day<\/h2>\n<\/div><\/div><\/div>
Radiopharmacy theme day: Saxony’s Economics Minister Dirk Panter visits innovation drivers in Dresden and Radeberg   Saxony’s Minister of Economics\u2026<\/div>
<\/i><\/i><\/span>

Carola Graf<\/h1>\n<\/div><\/div><\/div><\/article><\/a>
\"Featured<\/span><\/figure>

24. November 2025<\/h3>\n<\/div><\/div><\/div>

25 years of ROTOP<\/h2>\n<\/div><\/div><\/div>
ROTOP launches largest radiopharmaceutical investment program in Germany with a double-digit million amount   Dresden-Rossendorf, November 21, 2025 – ROTOP\u2026<\/div>
<\/i><\/i><\/span>

Carola Graf<\/h1>\n<\/div><\/div><\/div><\/article><\/a>
\"Featured<\/span><\/figure>

10. October 2025<\/h3>\n<\/div><\/div><\/div>

Bad prospects for cancer<\/h2>\n<\/div><\/div><\/div>
Radiopharmaceuticals “Made in Dresden-Rossendorf”: ROTOP continues to grow Jens Junker has been Managing Director of Rotop Pharmaka GmbH in Dresden\u2026<\/div>
<\/i><\/i><\/span>

Carola Graf<\/h1>\n<\/div><\/div><\/div><\/article><\/a>
\"Featured<\/span><\/figure>

9. October 2025<\/h3>\n<\/div><\/div><\/div>

Successful Hi-Tech meets Life Science Forum: Radiopharmacy in Saxony<\/h2>\n<\/div><\/div><\/div>
Successful Hi-Tech meets Life Science Forum Radiopharmacy in Saxony   Expanding added value – strengthening the radiopharmaceutical ecosystem in Saxony\u2026<\/div>
<\/i><\/i><\/span>

sysadmin<\/h1>\n<\/div><\/div><\/div><\/article><\/a>
\"Featured<\/span><\/figure>

9. October 2025<\/h3>\n<\/div><\/div><\/div>

Hi-Tech meets Life Science Forum: Radiopharmacy in Saxony<\/h2>\n<\/div><\/div><\/div>
Die Radiopharmazie in Europa steht am Beginn einer neuen \u00c4ra \u2013 und Sachsen kann eine Schl\u00fcsselrolle einnehmen. Erleben Sie ein\u2026<\/div>
<\/i><\/i><\/span>

Carola Graf<\/h1>\n<\/div><\/div><\/div><\/article><\/a>
\"Featured<\/span><\/figure>

7. October 2025<\/h3>\n<\/div><\/div><\/div>

Successful nukliD lunch session at the EANM 2025 in Barcelona<\/h2>\n<\/div><\/div><\/div>
Successful nukliD lunch session at the EANM 2026 in Barcelona A lively lunch session organized by Wirtschaftsf\u00f6rderung Sachsen GmbH (WFS)\u2026<\/div>
<\/i><\/i><\/span>

Carola Graf<\/h1>\n<\/div><\/div><\/div><\/article><\/a><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>

LinkedIn<\/h2>\n<\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>
Isabell Hilger<\/span>\n<\/div><\/div><\/div><\/div>

#nukliD #Radiopharmazie #Innovation #Vernetzung\n<\/p>\n<\/div><\/div><\/div>

Die Themen und Akteure aus dem SNRT-Projekt sind eng mit nukliD verbunden.<\/h3>\n<\/div><\/div><\/div>
Mehrere Projektpartner sind bereits Teil unseres Netzwerks, weitere Akteure m\u00f6chten sich perspektivisch anschlie\u00dfen. Das zeigt: die Herausforderungen und Chancen entlang der radiopharmazeutischen Wertsch\u00f6pfungskette lassen sich am\u2026<\/div>
12.05.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
CUP Contract Labs<\/span>\n<\/div><\/div><\/div><\/div>

#nukliD #Radiopharmacy #Collaboration #Innovation\n<\/p>\n<\/div><\/div><\/div>

Thank you CUP Contract Labs for hosting our latest nukliD network meeting.<\/h3>\n<\/div><\/div><\/div>
Great discussions, valuable insights and once again a strong reminder of what becomes possible when research, clinics and industry work together across the radiopharmaceutical value chain.\u2026<\/div>
07.05.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
<\/span>\n<\/div><\/div><\/div><\/div>

#Radiopharma #Innovation #Gesundheitsversorgung #nukliD\n<\/p>\n<\/div><\/div><\/div>

Radiopharma trifft Versorgung Beim Besuch des Vorstands der AOK PLUS Ilona Wojnowski am Hel\u2026<\/h3>\n<\/div><\/div><\/div>
Radiopharma trifft Versorgung Beim Besuch des Vorstands der AOK PLUS Ilona Wojnowski am Helmholtz-Zentrum Dresden-Rossendorf (HZDR) wurde eines sehr deutlich: Innovation allein reicht nicht \u2013 sie\u2026<\/div>
05.05.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
<\/span>\n<\/div><\/div><\/div><\/div>

#nukliD #Theranostics #Radiopharmacy #Leadership\n<\/p>\n<\/div><\/div><\/div>

Three strong days of theranostics in motion \u2013 from Cottbus to Dresden.<\/h3>\n<\/div><\/div><\/div>
Many thanks to Theranosticum Lausitz for the invitation and the excellent kick-off last week. It was great to see how quickly a dynamic ecosystem is taking\u2026<\/div>
04.05.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
Dresden Tomorrow's Home (Wirtschaftsf\u00f6rderung Dresden)<\/span>\n<\/div><\/div><\/div><\/div>

\n<\/p>\n<\/div><\/div><\/div>

Unser Netzwerk lebt \u2013 und genau solche Signale zeigen, wie Dynamik und Zusammenarbeit am St\u2026<\/h3>\n<\/div><\/div><\/div>
Unser Netzwerk lebt \u2013 und genau solche Signale zeigen, wie Dynamik und Zusammenarbeit am Standort wachsen. Herzlichen Gl\u00fcckwunsch an unseren Gr\u00fcndungspartner ROTOP Pharmaka GmbH!<\/div>
27.04.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
ROTOP Pharmaka GmbH<\/span>\n<\/div><\/div><\/div><\/div>

#Radiopharmacy #ValueChain #ScaleUp #RadioligandTherapy\n<\/p>\n<\/div><\/div><\/div>

Scale is the bottleneck \u2013 Dresden delivers!<\/h3>\n<\/div><\/div><\/div>
With the new manufacturing facility, ROTOP Pharmaka GmbH is tackling on of the key challenge in radiopharmaceuticals: the transition from clinical development to commercial supply RLT\u2026<\/div>
27.04.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
<\/span>\n<\/div><\/div><\/div><\/div>

#nukliD #Radiopharma #DGN #Collaboration\n<\/p>\n<\/div><\/div><\/div>

nukliD\u00ae auf der Deutsche Gesellschaft f\u00fcr Nuklearmedizin e.<\/h3>\n<\/div><\/div><\/div>
V. (DGN) \u2013 getragen von den Partnern! Danke an ABX advanced biochemical compounds GmbH f\u00fcr die Sichtbarkeit vor Ort! Wer mehr \u00fcber unser Radiopharmazie Netzwerk erfahren\u2026<\/div>
24.04.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
<\/span>\n<\/div><\/div><\/div><\/div>

\n<\/p>\n<\/div><\/div><\/div>

Radiopharmazie geh\u00f6rt auf die Hightech-Agenda Deutschland!<\/h3>\n<\/div><\/div><\/div>
Und genau das durfte nukliD mit Dr. Peggy Jungke gestern beim CDU\/CSU Innovationskongress in Berlin direkt bei den politischen Akteuren Dorothee B\u00e4r Jens Spahn pitchen. Deutschland\u2026<\/div>
16.04.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
DHBW Mannheim<\/span>\n<\/div><\/div><\/div><\/div>

#Radiopharmazie #\u00d6kosystem #Fachkr\u00e4fte #Radiopharma\n<\/p>\n<\/div><\/div><\/div>

Starker Impuls f\u00fcr ein zentrales Zukunftsthema der #Radiopharmazie \ud83d\udc4f Gemeinsam mit DHBW Man\u2026<\/h3>\n<\/div><\/div><\/div>
Starker Impuls f\u00fcr ein zentrales Zukunftsthema der \ud83d\udc4f Gemeinsam mit DHBW Mannheim hat Oliver Ki\u00df Helmholtz-Zentrum Dresden-Rossendorf (HZDR) mit Studierenden beleuchtet, wie sich der Arbeitsmarkt in\u2026<\/div>
01.04.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
VentureCapital Magazin<\/span>\n<\/div><\/div><\/div><\/div>

#Theranostics #nukliD #Radiopharma\n<\/p>\n<\/div><\/div><\/div>

Great to see VC Magazin highlighting #Theranostics as a key driver in the future of healthc\u2026<\/h3>\n<\/div><\/div><\/div>
Great to see VC Magazin highlighting as a key driver in the future of healthcare \u2013 and featuring nukliD\u00ae in this context. Theranostics is not just\u2026<\/div>
31.03.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
CUP Contract Labs<\/span>\n<\/div><\/div><\/div><\/div>

#Radiolabeling #Radiopharmazie #GMP-Expertise #Radiopharma\n<\/p>\n<\/div><\/div><\/div>

#Radiolabeling entscheidet \u00fcber Erfolg oder Misserfolg in der #Radiopharmazie.<\/h3>\n<\/div><\/div><\/div>
entscheidet \u00fcber Erfolg oder Misserfolg in der . Genau diese \u2013 von Development bis QC \u2013 haben wir im nukliD\u00ae Netzwerk mit unserem Partner CUP Contract\u2026<\/div>
26.03.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div>
<\/div><\/div>
<\/span>\n<\/div><\/div><\/div><\/div>

#Schl\u00fcsselinfrastruktur #Wertsch\u00f6pfungskette #Diagnostik #Transfer\n<\/p>\n<\/div><\/div><\/div>

Meilenstein f\u00fcr radiopharmazeutische Krebsforschung und Pr\u00e4zisionsmedizin: HZDR erh\u00e4lt F\u00f6rdermittel in Millionenh\u00f6he f\u00fcr Ganzk\u00f6rper-PET - Helmholtz-Zentrum Dresden-Rossendorf, HZDR<\/h3>\n<\/div><\/div><\/div>
Ein wichtiger Baustein in der Wertsch\u00f6pfungskette f\u00fcr Radiotheranostika und innovativer PET-Bildgebung Die Einwerbung von F\u00f6rdermitteln f\u00fcr ein Ganzk\u00f6rper-PET-System (GK-PET) erlaubt dem Helmholtz-Zentrum Dresden-Rossendorf (HZDR) die Beschaffung\u2026<\/div>
16.03.2026<\/div>
View on LinkedIn<\/span><\/div><\/div><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
<\/i><\/a><\/i><\/a><\/div><\/div>